RECRUITING
I'm interested ...!!
Activity Monitoring in Pulmonary Hypertension
This is a prospective, longitudinal, observational study of free-living activity trackers and patient reported outcomes to test the hypothesis that daily activity will have stronger prognostic value than 6MWD in patients with pulmonary hypertension after 12 weeks.
Conditions:
🦠 Pulmonary Hypertension
🗓️ Study Start (Actual) 24 October 2019
🗓️ Primary Completion (Estimated) June 2026
✅ Study Completion (Estimated) June 2026
👥 Enrollment (Estimated) 500
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Nashville, Tennessee, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Enrolled in L-PVDOMICS or
    • * Any patient in the United States with pulmonary hypertension confirmed by hemodynamics and expert clinical diagnosis

    Exclusion Criteria:

    • * Pregnancy
    • * Hospitalization within the prior 3 months
    • * Orthopedic limitations that preclude 6MWD testing
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 16 September 2019
  • First Submitted that Met QC Criteria 23 September 2019
  • First Posted 24 September 2019

Study Record Updates

  • Last Update Submitted that Met QC Criteria 25 September 2023
  • Last Update Posted 26 September 2023
  • Last Verified September 2023
I'm interested ...!!